Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bumetanide in Parkinson's Disease
NCT03899324Phase 2Unknown
- Sponsor
- B&A Therapeutics
- Start
- Apr 2019
- Primary completion
- Sep 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bumetanide in Parkinson's disease (PD), sponsored by B&A Therapeutics. Status: unknown.
02
Drugs
bumetanide
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT03899324.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03899324.